Amoeba SA
PAR:ALMIB

Watchlist Manager
Amoeba SA Logo
Amoeba SA
PAR:ALMIB
Watchlist
Price: 0.77 EUR -1.28% Market Closed
Market Cap: 38.2m EUR
Have any thoughts about
Amoeba SA?
Write Note

Amoeba SA
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amoeba SA
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Amoeba SA
PAR:ALMIB
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Robertet SA
PAR:RBT
Other Long-Term Assets
€7.4m
CAGR 3-Years
69%
CAGR 5-Years
41%
CAGR 10-Years
23%
Baikowski SA
PAR:ALBKK
Other Long-Term Assets
€2.1m
CAGR 3-Years
46%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Sergeferrari Group SA
PAR:SEFER
Other Long-Term Assets
€5.3m
CAGR 3-Years
-13%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Orapi SA
PAR:ORAP
Other Long-Term Assets
€2m
CAGR 3-Years
-42%
CAGR 5-Years
13%
CAGR 10-Years
26%
G
Groupe Berkem SA
PAR:ALKEM
Other Long-Term Assets
€1.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Amoeba SA
Glance View

Market Cap
38.2m EUR
Industry
Chemicals

Amoéba SA engages in developing, manufacturing and biological products. The company is headquartered in Chassieu, Auvergne-Rhone-Alpes and currently employs 22 full-time employees. The company went IPO on 2015-07-10. The firm specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The firm's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The firm is engaged in various technical, commercial, industrial and investment partnerships.

ALMIB Intrinsic Value
0.25 EUR
Overvaluation 67%
Intrinsic Value
Price

See Also

Back to Top